OyaGen Inc.

Biotechnology company · Rochester, New York, United States

OyaGen Inc. is a biotechnology company headquartered in Rochester, New York, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $345,000 sold in a notice filed in 2017.

www.oyageninc.comProfile compiled from public records. Is this your company? Request a correction or update

OyaGen at a glance

Typebiotechnology company
HeadquartersRochester, New York, United States
Employees (self-reported, 2023)5
SEC CIK1319956

What does OyaGen do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2018 to 2023). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $345,000 sold (2017).

Frequently asked questions about OyaGen

Where is OyaGen headquartered?

OyaGen Inc. is headquartered in Rochester, New York, United States.

What does OyaGen do?

OyaGen Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences